Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative versus postoperative rectal misoprostol for reducing blood loss at caesarean section
PACTR202608855940459Not yet recruiting
- Sponsor
- Self
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Self. Primary endpoint: Change in haemoglobin as surrogate for blood loss. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202608855940459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608855940459.